|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Part 6: Cardiovascular Complications in PD |
University Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, PR China
Correspondence to: A.Y.M. Wang, University Department of Medicine, Queen Mary Hospital, University of Hong Kong, 102 Pokfulam Road, Hong Kong SAR, PR China. aymwang{at}hku.hk
End-stage renal disease patients are at a heightened risk of developing
cardiovascular disease, with contributions from both "traditional"
and "nontraditional" cardiovascular risk factors. Some of the
nontraditional risk factors, such as extracellular volume overload,
inflammation, and hyperphosphatemia, have also been shown to be important
predictors of mortality in the dialysis population. This article provides an
in-depth review of the evidence that supports the substantial contributions of
nontraditional risk factors to adverse cardiovascular outcomes in chronic
peritoneal dialysis patients. In addition, it provides evidence to demonstrate
how loss of residual renal function may be central to the development of
cardiovascular disease in the peritoneal dialysis population.
KEY WORDS: Cardiovascular; residual renal function; inflammation; calcification; cardiac hypertrophy.
This article has been cited by other articles:
![]() |
A Power, N Duncan, and C Goodlad Management of the dialysis patient for the hospital physician Postgrad. Med. J., July 1, 2009; 85(1005): 376 - 381. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |